Found: 38
Select item for more details and to access through your institution.
Molecular Profiling and Survival of Completely Resected Primary Pulmonary Neuroendocrine Carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III trial (AENEAS).
- Published in:
- Cancer Communications, 2024, v. 44, n. 9, p. 1005, doi. 10.1002/cac2.12594
- By:
- Publication type:
- Article
A Low-Hydroxyl Quartz Glass Prepared by Using a Plasma Heat Source as the Flame and High-Purity Quartz Sand as the Raw Material.
- Published in:
- Applied Sciences (2076-3417), 2024, v. 14, n. 19, p. 9137, doi. 10.3390/app14199137
- By:
- Publication type:
- Article
Renal metastasis after esophagectomy of esophageal squamous cell carcinoma: a case report and literature review.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.
- Published in:
- World Journal of Surgical Oncology, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1477-7819-12-148
- By:
- Publication type:
- Article
Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?
- Published in:
- World Journal of Surgical Oncology, 2012, v. 10, n. 1, p. 173, doi. 10.1186/1477-7819-10-173
- By:
- Publication type:
- Article
Frontispiz: Platelet‐Drug Conjugates Engineered via One‐step Fusion Approach for Metastatic and Postoperative Cancer Treatment.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 37, p. 1, doi. 10.1002/ange.202483762
- By:
- Publication type:
- Article
Platelet‐Drug Conjugates Engineered via One‐step Fusion Approach for Metastatic and Postoperative Cancer Treatment.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 37, p. 1, doi. 10.1002/ange.202403541
- By:
- Publication type:
- Article
Chloride Ion Penetration Resistance of Reactive Powder Concrete with Mineral Admixtures.
- Published in:
- Materials Science / Medziagotyra, 2024, v. 30, n. 2, p. 233, doi. 10.5755/j02.ms.34962
- By:
- Publication type:
- Article
Crystallization process and luminescence properties of LaBO<sub>3</sub> glass ceramics.
- Published in:
- Journal of Materials Science: Materials in Electronics, 2023, v. 34, n. 19, p. 1, doi. 10.1007/s10854-023-10860-6
- By:
- Publication type:
- Article
Flower‐like shaped Bi<sub>12</sub>TiO<sub>20</sub>/g‐C<sub>3</sub>N<sub>4</sub> heterojunction for effective elimination of organic pollutants: Preparation, characterization, and mechanism study.
- Published in:
- Applied Organometallic Chemistry, 2020, v. 34, n. 8, p. 1, doi. 10.1002/aoc.5702
- By:
- Publication type:
- Article
Efficacy of Icotinib for Advanced Non-small Cell Lung Cancer Patients with EGFR Status Identified.
- Published in:
- Chinese Journal of Lung Cancer, 2013, v. 16, n. 3, p. 138, doi. 10.3779/j.issn.1009-3419.2013.03.04
- By:
- Publication type:
- Article
Prognostic value of programed death ligand 1 in patients with solid tumors: A meta-analysis.
- Published in:
- Journal of Cancer Research & Therapeutics, 2015, v. 11, p. C38, doi. 10.4103/0973-1482.163837
- By:
- Publication type:
- Article
Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: A systematic review with meta-analysis.
- Published in:
- Journal of Cancer Research & Therapeutics, 2014, v. 10, p. C160, doi. 10.4103/0973-1482.145854
- By:
- Publication type:
- Article
Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: A systematic review with meta-analysis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Docetaxel-based chemotherapy as second-line regimen for advanced thymic carcinoma.
- Published in:
- Thoracic Cancer, 2014, v. 5, n. 2, p. 169, doi. 10.1111/1759-7714.12064
- By:
- Publication type:
- Article
A real‑world study of treatment patterns and survival outcome in advanced anaplastic lymphoma kinase‑positive non‑small‑cell lung cancer.
- Published in:
- Oncology Letters, 2018, v. 15, n. 6, p. 8703, doi. 10.3892/ol.2018.8444
- By:
- Publication type:
- Article
Circulating tumor DNA serial monitoring of relapse and responses to tislelizumab immunotherapy as second‑line monotherapy for metastatic esophageal squamous cell carcinoma: A prospective study.
- Published in:
- Molecular & Clinical Oncology, 2024, v. 20, n. 4, p. N.PAG, doi. 10.3892/mco.2024.2727
- By:
- Publication type:
- Article
Frontispiece: Platelet‐Drug Conjugates Engineered via One‐step Fusion Approach for Metastatic and Postoperative Cancer Treatment.
- Published in:
- Angewandte Chemie International Edition, 2024, v. 63, n. 37, p. 1, doi. 10.1002/anie.202483762
- By:
- Publication type:
- Article
Platelet‐Drug Conjugates Engineered via One‐step Fusion Approach for Metastatic and Postoperative Cancer Treatment.
- Published in:
- Angewandte Chemie International Edition, 2024, v. 63, n. 37, p. 1, doi. 10.1002/anie.202403541
- By:
- Publication type:
- Article
Apatinib for chemotherapy-refractory extensive-stage SCLC: a retrospective study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2019, v. 83, n. 6, p. 1083, doi. 10.1007/s00280-019-03823-4
- By:
- Publication type:
- Article
Apatinib for chemotherapy-refractory extensive-stage SCLC: a retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3).
- Published in:
- Cancer Communications, 2022, v. 42, n. 12, p. 1314, doi. 10.1002/cac2.12385
- By:
- Publication type:
- Article
Tunlametinib (HL-085) plus vemurafenib in patients with advanced BRAF V600-mutant solid tumors: an open-label, single-arm, multicenter, phase I study.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00528-0
- By:
- Publication type:
- Article
Tunlametinib (HL-085) plus vemurafenib in patients with advanced BRAF V600-mutant solid tumors: an open-label, single-arm, multicenter, phase I study.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00528-0
- By:
- Publication type:
- Article
Late-model g-CNQDs/H<sub>3</sub>PW<sub>12</sub>O<sub>40</sub>/TiO<sub>2</sub> heterojunction nanocatalyst with enhanced photocatalytic performance.
- Published in:
- Journal of Materials Science, 2020, v. 55, n. 31, p. 15152, doi. 10.1007/s10853-020-05083-7
- By:
- Publication type:
- Article
Salvage treatment with apatinib for advanced non-small-cell lung cancer.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 1821, doi. 10.2147/OTT.S113435
- By:
- Publication type:
- Article
Rare frequency of gene variation and survival analysis in thymic epithelial tumors.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 6337, doi. 10.2147/OTT.S108749
- By:
- Publication type:
- Article
Recent updates on electrochemical degradation of bio-refractory organic pollutants using BDD anode: a mini review.
- Published in:
- Environmental Science & Pollution Research, 2014, v. 21, n. 14, p. 8417, doi. 10.1007/s11356-014-2820-0
- By:
- Publication type:
- Article
Nanoscale zero-valent iron/AC as heterogeneous Fenton catalysts in three-dimensional electrode system.
- Published in:
- Environmental Science & Pollution Research, 2014, v. 21, n. 14, p. 8398, doi. 10.1007/s11356-014-2791-1
- By:
- Publication type:
- Article
Improved corrosion resistance of Al<sub>2</sub>O<sub>3</sub>‐SiC‐C castables through in situ carbon containing aluminate cement as binder.
- Published in:
- International Journal of Applied Ceramic Technology, 2020, v. 17, n. 3, p. 1044, doi. 10.1111/ijac.13474
- By:
- Publication type:
- Article
Mutation and prognostic analyses of PIK3 CA in patients with completely resected lung adenocarcinoma.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 10, p. 2694, doi. 10.1002/cam4.852
- By:
- Publication type:
- Article
Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.572853
- By:
- Publication type:
- Article
Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non–Small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00480
- By:
- Publication type:
- Article
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparison of the 7<sup>th</sup> and proposed 8<sup>th</sup> editions of the AJCC/UICC TNM staging system for non-small cell lung cancer undergoing radical surgery.
- Published in:
- Scientific Reports, 2016, p. 33587, doi. 10.1038/srep33587
- By:
- Publication type:
- Article
Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer.
- Published in:
- Scientific Reports, 2016, p. 31636, doi. 10.1038/srep31636
- By:
- Publication type:
- Article